VIKING THERAPEUTICS INC

NASDAQ: VKTX (Viking Therapeutics, Inc.)

Last update: 8 hours ago

37.42

1.76 (4.94%)

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bullish Bullish
Biotechnology (Global) Bullish Bullish
Stock Viking Therapeutics, Inc. - -

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Sector Healthcare
Industry Biotechnology
Investment Style Small Growth

Ownership

Name Date Shares Held
Viking Global Investors Lp 31 Dec 2023 5,145,112
Balyasny Asset Management L.P. 31 Dec 2023 2,243,523
Deerfield Management Company, L.P. (Series C) 31 Dec 2023 1,279,000
Deutsche Bank Ag\ 31 Dec 2023 859,691
52 Weeks Range
8.28 - 38.68
Price Target Range
35.00 - 50.00
High 50.00 (Maxim Group, 33.62%) Buy
Median 42.50 (13.58%)
Low 35.00 (Stifel, -6.47%) Buy
Average 42.50 (13.58%)
Total 2 Buy
Firm Date Target Price Call Price @ Call
Stifel 14 Feb 2024 35.00 (-6.47%) Buy 32.23
Maxim Group 08 Feb 2024 50.00 (33.62%) Buy 28.89

No data within this time range.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No data